Blackhawk Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TIM
Blackhawk Capital Partners's PFE Position: Q1 2025 in Review
Blackhawk Capital Partners sold out of Pfizer (PFE) in Q1 2025, closing a stake of 17,267 shares — an estimated $458K sold.
Blackhawk Capital Partners first reported a position in PFE in Q4 2017 and held it in 14 quarters. The position peaked at $2.1M in Q2 2019. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Blackhawk Capital Partners reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Blackhawk Capital Partners sold 17,267 Pfizer shares in Q1 2025, an estimated $458K.
- Blackhawk Capital Partners first reported a position in Pfizer in Q4 2017 and held it in 14 quarters.
- Blackhawk Capital Partners's Pfizer position peaked at $2.1M in Q2 2019.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Blackhawk Capital Partners's 13F filing for Q1 2025, filed 30 Apr 2025.